Medical panel adjusts Insurer scores in eight high incidence conditions
With the help of a panel of medical professionals, Finance & Technology Research Centre's (FTRC) reviews critical illness wordings within its product comparison tool Quality Analyser every six months. As a result of the review, insurer scores have been adjusted in eight high incidence conditions. These include: Benign brain tumour, carcinoma in situ of the colon or rectum, carcinoma in situ of the cervix, low grade prostate cancer, cardiomyopathy, coronary angioplasty, Parkinson's disease and...
According to gender and different ages
'Advisers... don't be lazy'
Upgrade moves insurer 'back up quality tables'
Critical illness updates